Literature DB >> 8943304

Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element.

A Sturrock1, K F Franklin, J R Hoidal.   

Abstract

Human proteinase-3 is one of three serine proteinases present in the azurophil granules of polymorphonuclear leukocytes along with elastase and cathepsin G. Proteinase-3 gene expression is confined to the promyelocytic stage of polymorphonuclear leukocyte maturation. The present investigation identifies elements responsible for this highly controlled tissue- and developmental-specific expression of proteinase-3. Within the first 200 base pairs of the proteinase-3 promoter, two elements were identified as important for expression, these elements at -101 and -190 confer the majority of the activity. The element at -101 has a PU.1 consensus. It binds a myeloid nuclear protein of approximately 45 kDa that "supershifts" with PU.1 antibody and is competed by the CD11b PU.1 element. The element at -190 has a core sequence of CCCCGCCC (CG element). The cytidines but not the guanidine are essential for promoter activity. The CG element binds a second nuclear protein with a molecular mass of approximately 40 kDa that is found in cells of myeloid lineage as well as non-myeloid HeLa cells. However, the proteinase-3 promoter is not active in HeLa cells which suggests that the CG element alone is not sufficient for proteinase-3 gene expression. Maturation of promyelocytic cells results in an inhibition of proteinase-3 gene expression and a reduction in nuclear protein binding to the PU.1 and CG elements. Similar elements occur in the elastase and cathepsin G promoters. Using the elastase and cathepsin G PU.1 and CG-like elements as probes results in identical band-shift patterns to that obtained with proteinase-3 PU.1 and CG elements. These data suggest that there is cooperative interaction between a PU.1 and a CG element with a consensus of CCCCXCCC and that they are important control elements for tissue- and developmental-specific expression of azurophil serine proteinases of polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943304     DOI: 10.1074/jbc.271.50.32392

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

Authors:  Mao Zhang; Pariya Sukhumalchandra; Atim A Enyenihi; Lisa S St John; Sally A Hunsucker; Elizabeth A Mittendorf; Anna Sergeeva; Kathryn Ruisaard; Zein Al-Atrache; Patricia A Ropp; Haroon Jakher; Tania Rodriguez-Cruz; Gregory Lizee; Karen Clise-Dwyer; Sijie Lu; Jeffrey J Molldrem; Gary L Glish; Paul M Armistead; Gheath Alatrash
Journal:  Clin Cancer Res       Date:  2012-11-12       Impact factor: 12.531

Review 2.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

3.  An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.

Authors:  Anna Sergeeva; Gheath Alatrash; Hong He; Kathryn Ruisaard; Sijie Lu; James Wygant; Bradley W McIntyre; Qing Ma; Dan Li; Lisa St John; Karen Clise-Dwyer; Jeffrey J Molldrem
Journal:  Blood       Date:  2011-02-04       Impact factor: 22.113

4.  The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.

Authors:  K Pieters; A Pettersson; U Gullberg; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.

Authors:  Gheath Alatrash; Yoko Ono; Anna Sergeeva; Pariya Sukhumalchandra; Mao Zhang; Lisa S St John; Tian-Hui Yang; Kathryn Ruisaard; Paul M Armistead; Elizabeth A Mittendorf; Hong He; Na Qiao; Tania Rodriguez-Cruz; Shoudan Liang; Karen Clise-Dwyer; Eric D Wieder; Gregory Lizee; Sijie Lu; Jeffrey J Molldrem
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

6.  Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.

Authors:  Britta E Jones; Jiajin Yang; Akhil Muthigi; Susan L Hogan; Yichun Hu; Joshua Starmer; Candace D Henderson; Caroline J Poulton; Elizabeth J Brant; William F Pendergraft; J Charles Jennette; Ronald J Falk; Dominic J Ciavatta
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

7.  Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha.

Authors:  A Iwama; P Zhang; G J Darlington; S R McKercher; R Maki; D G Tenen
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

8.  Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.

Authors:  Holger Brockmann; Andreas Schwarting; Jörg Kriegsmann; Peter Petrow; Andreas Gaumann; Klaus-Michael Müller; Peter Robert Galle; Werner Mayet
Journal:  Arthritis Res       Date:  2002-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.